Xenograft ovarian tumor response to anti-cancer therapeutic MT19: time course
Summary:
Analysis of ovarian xenograft tumors from nude mice inoculated with SKOV-3 cells then treated with anti-cancer agent MT19c. Xenograft tumors collected up to 30 days after initiation of MT19c treatment. Results provide insight into molecular mechanisms underlying ovarian xenograft tumor progression.
GPL6244:
[HuGene-1_0-st] Affymetrix Human Gene 1.0 ST Array [transcript (gene) version]
Citation:
Stuckey A, Fischer A, Miller DH, Hillenmeyer S et al. Integrated genomics of ovarian xenograft tumor progression and chemotherapy response. BMC Cancer 2011 Jul 22;11:308. PMID: 21781307
